Based on the therapeutic effects of CTRP1 on HFD-induced obesity and STZ-induced T2DM mice, the obese mouse model was established to investigate whether CTRP1 can improve glucose metabolism and decrease body weight. The gene discussed is C1QTNF1; the disease is type 2 diabetes mellitus.